Literature DB >> 17108220

Circulating nucleic acids and critical illness.

Timothy H Rainer1, Nicole Y L Lam.   

Abstract

This article reviews some of the early work that has been performed to investigate the potential roles of circulating nucleic acids as prediction markers in acute illness and injury. Circulating DNA and RNA concentrations are elevated early in patients with trauma, stroke and ACS, and are generally highest in patients with a high risk of death. Circulating nucleic acids may be useful markers for the evaluation and risk-stratification of such patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108220     DOI: 10.1196/annals.1368.035

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Astrogliosis involves activation of retinoic acid-inducible gene-like signaling in the innate immune response after spinal cord injury.

Authors:  Juan Pablo de Rivero Vaccari; Julia Minkiewicz; Xiaoliang Wang; Juan Carlos De Rivero Vaccari; Ramon German; Alex E Marcillo; W Dalton Dietrich; Robert W Keane
Journal:  Glia       Date:  2011-12-07       Impact factor: 7.452

Review 2.  Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.

Authors:  Paola Ulivi; Rosella Silvestrini
Journal:  Cell Oncol (Dordr)       Date:  2013-11-01       Impact factor: 6.730

Review 3.  Clinical applications of liquid biopsies for early lung cancer detection.

Authors:  Hao Zheng; Xin Wu; Jie Yin; Shuang Wang; Zhi Li; Changxuan You
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

4.  Hydrogel-Coated Microneedle Arrays for Minimally Invasive Sampling and Sensing of Specific Circulating Nucleic Acids from Skin Interstitial Fluid.

Authors:  Dana Al Sulaiman; Jason Y H Chang; Nitasha R Bennett; Helena Topouzi; Claire A Higgins; Darrell J Irvine; Sylvain Ladame
Journal:  ACS Nano       Date:  2019-08-16       Impact factor: 15.881

Review 5.  Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Authors:  Marius Ilie; Véronique Hofman; Elodie Long; Olivier Bordone; Eric Selva; Kevin Washetine; Charles Hugo Marquette; Paul Hofman
Journal:  Ann Transl Med       Date:  2014-11

6.  Environmentally induced ribosomal DNA (rDNA) instability in human cells and populations exposed to hexavalent chromium [Cr (VI)].

Authors:  Jianlin Lou; Shoukai Yu; Lingfang Feng; Xinnian Guo; Meng Wang; Alan T Branco; Tao Li; Bernardo Lemos
Journal:  Environ Int       Date:  2021-03-25       Impact factor: 13.352

7.  Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer.

Authors:  Eveline E Vietsch; Casper Hj van Eijck; Anton Wellstein
Journal:  Pancreat Disord Ther       Date:  2015-06

8.  Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients.

Authors:  Lei Wang; Liang Xie; Qigao Zhang; Xiaomin Cai; Yi Tang; Lijun Wang; Tao Hang; Jing Liu; Jianbin Gong
Journal:  Coron Artery Dis       Date:  2015-06       Impact factor: 1.439

9.  RIG-1 receptor expression in the pathology of Alzheimer's disease.

Authors:  Juan Pablo de Rivero Vaccari; Frank J Brand; Christina Sedaghat; Deborah C Mash; W Dalton Dietrich; Robert W Keane
Journal:  J Neuroinflammation       Date:  2014-04-02       Impact factor: 8.322

10.  The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries.

Authors:  Gad Shaked; Amos Douvdevani; Silvia Yair; Alexander Zlotnik; David Czeiger
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-03-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.